These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7812459

  • 21. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ, Manjila S, Mehndiratta P, Khan F, Miller BR, Onwuzulike K, Puoti G, Cohen ML, Schonberger LB, Cali I.
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Cerebral magnetic resonance imaging in iatrogenic Creutzfeldt-Jacob disease].
    Gurau C, Zeghoudi AC, Atlaoui-Rabia S, Charitanski D, Mallecourt J.
    Presse Med; 2005 Sep 10; 34(15):1080-1. PubMed ID: 16334885
    [Abstract] [Full Text] [Related]

  • 24. Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology.
    Duyckaerts C, Sazdovitch V, Ando K, Seilhean D, Privat N, Yilmaz Z, Peckeu L, Amar E, Comoy E, Maceski A, Lehmann S, Brion JP, Brandel JP, Haïk S.
    Acta Neuropathol; 2018 Feb 10; 135(2):201-212. PubMed ID: 29209767
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E.
    Acta Paediatr Scand Suppl; 1986 Feb 10; 325():116-24. PubMed ID: 3296633
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Epidemiological surveillance of Creutzfeldt-Jakob in France].
    Brandel JP, Salomon D, Capek I, Vaillant V, Alpérovitch A.
    Rev Neurol (Paris); 2009 Feb 10; 165(8-9):684-93. PubMed ID: 19467685
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Growth hormone and Creutzfeldt-Jakob disease].
    Goujard J.
    Rev Epidemiol Sante Publique; 1993 Feb 10; 41(6):513-4. PubMed ID: 8296041
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Iatrogenic Creutzfeldt-Jakob disease at the millennium.
    Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenáková L, Fradkin J, Schonberger LB, Collins SJ.
    Neurology; 2000 Oct 24; 55(8):1075-81. PubMed ID: 11071481
    [Abstract] [Full Text] [Related]

  • 39. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.
    Fisman M.
    N Engl J Med; 1986 Apr 10; 314(15):987-8. PubMed ID: 3515181
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.